Physician

Venu Gopal Bathini, M.D.

According to 2025 Medicare claims, Venu Bathini, M.D. (NPI: 1578658563) practices hematology/oncology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Middlesex, MA. This provider's primary affiliated billing organization is CHARLES RIVER MEDICAL ASSOCIATES PC (NPI: 1598215204; TIN: 043260427) and primary practice location at 01702-5855. Bathini is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Bathini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 169,932 HCPCS/CPT codes, and received $1,527,592 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 637 prescription claims across 136 beneficiaries totaling $975,338 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 14 claims. Open Payments data shows 23 records totaling $727. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $49,432 to $1,527,592. Similarly, Part D prescription costs have risen steadily, from $106,217 to $975,338. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	292	721	$49,432
2016	350	868	$61,361
2017	456	1,135	$76,552
2018	340	710	$52,776
2019	357	802	$64,313
2020	325	732	$63,079
2021	337	24,742	$222,254
2022	371	109,469	$1,072,709
2023	362	115,615	$1,142,330
2024	461	169,932	$1,527,592

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	54	205	$106,217
2016	59	255	$372,600
2017	78	399	$464,445
2018	60	224	$378,332
2019	55	200	$197,933
2020	60	252	$123,022
2021	62	189	$245,744
2022	74	415	$683,159
2023	102	527	$1,079,248
2024	136	637	$975,338

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	28	$24,300
2016	N/R	93	$52,858
2017	N/R	28	$15,253
2018	N/R	88	$15,989
2019	N/R	N/R	N/R
2020	N/R	14	$2,382
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	93	93	$179
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	165	352	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	238	494	$73
36415	Insertion of needle into vein for collection of blood sample	215	541	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	208	704	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	12	336	$197,578
Xtandi	Enzalutamide	11	330	$155,795
Eliquis	Apixaban	83	5,940	$113,527
Xarelto	Rivaroxaban	24	1,500	$26,506
Hydroxyurea	Hydroxyurea	53	4,374	$1,872

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$727	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Venu Gopal Bathini, M.D.?

Tedicare shows public-source Medicare data for Venu Gopal Bathini, M.D. (NPI 1578658563), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Venu Gopal Bathini, M.D. have ACO affiliation data?

Venu Gopal Bathini, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Venu Gopal Bathini, M.D.?

Venu Gopal Bathini, M.D. is linked to CHARLES RIVER MEDICAL ASSOCIATES PC (billing NPI 1598215204) in the available physician profile data.

Does Venu Gopal Bathini, M.D. have Open Payments data?

Venu Gopal Bathini, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.